These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

190 related items for PubMed ID: 15686918

  • 1. The evolution of synthetic oral drug properties.
    Proudfoot JR.
    Bioorg Med Chem Lett; 2005 Feb 15; 15(4):1087-90. PubMed ID: 15686918
    [Abstract] [Full Text] [Related]

  • 2. Dependence of molecular properties on proteomic family for marketed oral drugs.
    Vieth M, Sutherland JJ.
    J Med Chem; 2006 Jun 15; 49(12):3451-3. PubMed ID: 16759087
    [Abstract] [Full Text] [Related]

  • 3. [Strategy of molecular design of drugs: the unification of macro-properties and micro-structures of a molecule].
    Guo ZR.
    Yao Xue Xue Bao; 2008 Mar 15; 43(3):227-33. PubMed ID: 18630256
    [Abstract] [Full Text] [Related]

  • 4. Characteristics of known drug space. Natural products, their derivatives and synthetic drugs.
    Bade R, Chan HF, Reynisson J.
    Eur J Med Chem; 2010 Dec 15; 45(12):5646-52. PubMed ID: 20888084
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Hologram QSAR model for the prediction of human oral bioavailability.
    Moda TL, Montanari CA, Andricopulo AD.
    Bioorg Med Chem; 2007 Dec 15; 15(24):7738-45. PubMed ID: 17870541
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Influence of molecular flexibility and polar surface area metrics on oral bioavailability in the rat.
    Lu JJ, Crimin K, Goodwin JT, Crivori P, Orrenius C, Xing L, Tandler PJ, Vidmar TJ, Amore BM, Wilson AG, Stouten PF, Burton PS.
    J Med Chem; 2004 Nov 18; 47(24):6104-7. PubMed ID: 15537364
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. A comparison of physiochemical property profiles of development and marketed oral drugs.
    Wenlock MC, Austin RP, Barton P, Davis AM, Leeson PD.
    J Med Chem; 2003 Mar 27; 46(7):1250-6. PubMed ID: 12646035
    [Abstract] [Full Text] [Related]

  • 14. Time-related differences in the physical property profiles of oral drugs.
    Leeson PD, Davis AM.
    J Med Chem; 2004 Dec 02; 47(25):6338-48. PubMed ID: 15566303
    [Abstract] [Full Text] [Related]

  • 15. A timely reassessment of early prediction in the bioavailability of orally administered drugs.
    Larsen T, Link A.
    Angew Chem Int Ed Engl; 2005 Jul 18; 44(29):4432-4. PubMed ID: 15984039
    [No Abstract] [Full Text] [Related]

  • 16. Strategies to improve oral drug bioavailability.
    Gomez-Orellana I.
    Expert Opin Drug Deliv; 2005 May 18; 2(3):419-33. PubMed ID: 16296764
    [Abstract] [Full Text] [Related]

  • 17. Rationalizing the selection of oral lipid based drug delivery systems by an in vitro dynamic lipolysis model for improved oral bioavailability of poorly water soluble drugs.
    Dahan A, Hoffman A.
    J Control Release; 2008 Jul 02; 129(1):1-10. PubMed ID: 18499294
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. A simple approach for indexing the oral druglikeness of a compound: discriminating druglike compounds from nondruglike ones.
    Biswas D, Roy S, Sen S.
    J Chem Inf Model; 2006 Jul 02; 46(3):1394-401. PubMed ID: 16711759
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.